XML 53 R41.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation - Summary of Stock Option Activity (Details)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Shares Available to Grant, Beginning Balance 614,041  
Shares Available to Grant, Change in authorized shares 5,490,175  
Shares Available to Grant, Granted (3,016,584)  
Shares Available to Grant, Forfeited/expired 51,902  
Shares Available to Grant, Ending Balance 3,139,534 614,041
Number of Options, Beginning Balance 2,364,083  
Number of Options, Granted 3,016,584  
Number of Options, Exercised (79,987)  
Number of Options, Forfeited/expired (51,902)  
Number of Options, Ending Balance 5,248,778 2,364,083
Number of Options, Vested and Exercisable 1,951,828  
Weighted Average Exercise Price    
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 8.38  
Weighted Average Exercise Price, Granted | $ / shares 10.23  
Weighted Average Exercise Price, Exercised | $ / shares 7.62  
Weighted Average Exercise Price, Forfeited/expired | $ / shares 7.31  
Weighted Average Exercise Price, Ending Balance | $ / shares 9.47 $ 8.38
Weighted Average Exercise Price, Vested and Exercisable | $ / shares $ 8.08  
Weighted Average Remaining Contractual Term and Aggregate Intrinsic Value    
Weighted Average Remaining Contractual Life (Years) 8 years 4 months 24 days 7 years 4 months 24 days
Weighted Average Remaining Contractual Life (Years), Vested and Exercisable 6 years 8 months 12 days  
Aggregate Intrinsic Value, Beginning Balance | $ $ 2,864  
Aggregate Intrinsic Value, Ending Balance | $ 59,491 $ 2,864
Aggregate Intrinsic Value, Vested and Exercisable | $ $ 24,833